The advent of CRISPR & genome editing technologies has ushered in a new era of genetic precision, enabling targeted modifications with unprecedented accuracy. CRISPR-Cas systems allow scientists to cut, delete, or replace DNA sequences in a wide range of organisms, offering therapeutic possibilities for genetic diseases, cancer, and infectious conditions. Beyond CRISPR, novel editing tools like base editors and prime editors are expanding the genome editing toolkit. Researchers are now combining CRISPR & Genome Editing Technologies with delivery platforms such as viral vectors and nanoparticles to improve efficiency and specificity. These tools are also critical for functional genomics, crop enhancement, and synthetic biology. As ethical and regulatory frameworks evolve, genome editing remains one of the most transformative technologies in modern biotechnology.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Phage Display-Based Biosensing for Rapid Detection of Neonatal Group B Streptococcal (GBS) Infection
Md Monir Hossain, RMIT University, Australia
Title : Contribution of bioengineered food in addressing hunger and food and nutrition security (FNS)
Santosh Kumar Mishra , Department of Life Long Learning and Extension, S. N. D. T. Women’s University, India
Title : Engineering the future biotech workforce: A predictive framework for capability, reliability and digital innovation
Jason Beckwith, Biotalent, United Kingdom
Title : Lignocellulosic biomass to biofuels and biochemicals: Microbial innovations for a sustainable future
Gunjan Mukherjee, Chandigarh University, India